Search research articles
Contact Us
Filters
Showing results (591-600 of 616) with videos related to
Page
of 62
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2020
Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
V A Papadimitrakopoulou, T S Mok, J-Y Han, et al.
Stem Cells (Dayton, Ohio)
|
May 23, 2019
In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long-Term Hematopoietic Engraftment
Stavros P Loukogeorgakis, Panicos Shangaris, Enrica Bertin, et al.
Nature
|
July 26, 2023
Sub-1.4 cm<sup>3</sup> capsule for detecting labile inflammatory biomarkers in situ
M E Inda-Webb, M Jimenez, Q Liu, et al.
Breast Cancer Research and Treatment
|
September 13, 2021
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors
A Dilawari, K E Rentscher, W Zhai, et al.
Diabetes, Obesity & Metabolism
|
April 23, 2020
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)
Gyuri Kim, Soo Lim, Hyuk-Sang Kwon, et al.
ESMO Open
|
May 4, 2023
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer
G Galffy, I Lugowska, E V Poddubskaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
H R Kim, H N Kang, H S Shim, et al.
Journal of Pediatric Surgery
|
October 24, 2021
Urinary continence disparities in patients with anorectal malformations
Jennifer J Ahn, Samuel E Rice-Townsend, Lauren Nicassio, et al.
Journal of Pediatric Urology
|
January 11, 2024
Feasibility of Enhanced Recovery After Surgery (ERAS) implementation in Pediatric Urology: Pilot-phase outcomes of a prospective, multi-center study
Andrew C Strine, David I Chu, Megan A Brockel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
R S Herbst, P Baas, J L Perez-Gracia, et al.
Page
of 62
Search research articles
Search
Showing results (591-600 of 616) with videos related to
Sort By:
Page
of 62
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2020
Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
V A Papadimitrakopoulou, T S Mok, J-Y Han, et al.
Stem Cells (Dayton, Ohio)
|
May 23, 2019
In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long-Term Hematopoietic Engraftment
Stavros P Loukogeorgakis, Panicos Shangaris, Enrica Bertin, et al.
Nature
|
July 26, 2023
Sub-1.4 cm<sup>3</sup> capsule for detecting labile inflammatory biomarkers in situ
M E Inda-Webb, M Jimenez, Q Liu, et al.
Breast Cancer Research and Treatment
|
September 13, 2021
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors
A Dilawari, K E Rentscher, W Zhai, et al.
Diabetes, Obesity & Metabolism
|
April 23, 2020
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)
Gyuri Kim, Soo Lim, Hyuk-Sang Kwon, et al.
ESMO Open
|
May 4, 2023
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer
G Galffy, I Lugowska, E V Poddubskaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
H R Kim, H N Kang, H S Shim, et al.
Journal of Pediatric Surgery
|
October 24, 2021
Urinary continence disparities in patients with anorectal malformations
Jennifer J Ahn, Samuel E Rice-Townsend, Lauren Nicassio, et al.
Journal of Pediatric Urology
|
January 11, 2024
Feasibility of Enhanced Recovery After Surgery (ERAS) implementation in Pediatric Urology: Pilot-phase outcomes of a prospective, multi-center study
Andrew C Strine, David I Chu, Megan A Brockel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
R S Herbst, P Baas, J L Perez-Gracia, et al.
Page
of 62